查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1857951

经皮皮肾结石清除术市场按产品类型、手术类型、最终用户、技术、应用和病患类型划分－2025-2032年全球预测

Percutaneous Nephrolithotomy Market by Product Type, Procedure Type, End User, Technology, Application, Patient Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，经皮皮肾结石清除市场规模将达到 370.7 亿美元，复合年增长率为 8.24%。

关键市场统计数据
基准年 2024 196.6亿美元
预计年份：2025年 212.7亿美元
预测年份 2032 370.7亿美元
复合年增长率 (%) 8.24%

经皮肾镜取石术的权威概述，说明了当代临床实践、器械生态系统以及影响医疗服务的各种手术方法。

经皮肾镜取石术是现代泌尿系统治疗复杂及大型肾结石的基石。近年来，该手术已从最初的院内手术发展到如今多种入路方式，这些方式的特点在于不同的器械尺寸、能量模式和手术全期路径。这项发展得益于器械工程、光学技术和能量输送系统的同步进步，以及病患和支付方不断变化的需求，他们更重视缩短住院时间、加速復原速度和确保手术安全性。

在此背景下，临床团队通常会考虑一套完整的产品和手术方案。核心手术设备包括肾臟镜、碎石机以及各种配件，例如取石篮、扩张器、导管导引线和鞘套。手术方案涵盖微型、迷你、标准和超迷你等多种类型，每种方案都根据结石负荷、肾臟解剖结构和患者合併症量身定制。最终用户包括独立门诊手术中心、医院附属门诊手术中心、私人医院和公立医院，可以选择雷射、气动和超音波等技术。应用通常区分肾结石和更广泛的鹿角状结石，成人和儿童患者群体也存在差异。总而言之，这些要素共同构成了现代临床路径及其背后的商业性生态系统。

技术小型化、能源多样化和临床实践的演变如何重塑肾结石手术的临床常规和商业策略

经经皮肾结石清除术的格局正在经历多重变革，这些变革由技术、操作和以患者为中心的因素共同驱动。技术的微型化和内视镜光学技术的进步使得微创手术方案更加多样化，促使临床医生重新思考传统的结石尺寸阈值和手术全期要求。同时，能量平台也在不断多样化。雷射系统随着光纤设计和能量调製技术的改进而日益成熟；气动和超音波方式对于某些成分的结石仍然十分重要；此外，混合式方法也正在涌现，以优化结石的碎裂和排放。

在营运方面，门诊和早期復健模式正成为明显的趋势。随着临床医生和管理人员采用既能缩短住院时间又不影响安全性的通讯协定，手术选择和器械组合正在重新评估。供应链的韧性和成本效益也变得日益重要，促使医院和门诊中心重新协商服务合同，权衡一次性使用和重复使用之间的利弊，并探索战略采购方案。最后，监管机构的严格审查以及支付方对结果和价值的关注，促使製造商提供可靠的临床证据，并支持旨在促进新手术和器械安全应用的培训计画。

评估美国关税政策变化对2025年医疗设备采购、製造策略和医疗服务提供者采购行为的营运和采购影响

2025年影响关税和贸易的政策决定将对经皮取石术供应链产生重大影响。依赖跨国零件采购的製造商正面临到岸成本上升的困境，促使采购团队重新评估其资本设备、耗材和配件组合的总拥有成本。为此，一些供应商加快了对区域製造的投资，并调整了分销模式，以降低关税波动和货运中断带来的风险。

对于医疗服务提供者而言，累积效应体现在采购週期和库存管理的重新调整。医院和门诊中心与供应商的谈判更加严格，并评估了配套服务安排，以转移库存风险，同时确保能够获得先进的体外碎石和内视镜平台。临床医生观察到，成本压力影响了设备选择，促使他们在高端可重复使用系统和价格具有竞争力的单次使用替代方案之间做出选择，研发重点也转向了既能保持临床性能又具有成本效益的设计。同时，资本预算週期也进行了调整，以应对更长的前置作业时间和耗材价格的潜在波动，凸显了生命週期服务协议和临床证据对于证明更高初始投资合理性的重要性。

将产品类别、流程差异、终端用户需求、能量模式、临床应用和患者群体与购买和临床偏好联繫起来的可操作细分洞察

透过产品层面的细分，我们获得了洞察，揭示了不同设备类别如何影响临床决策和采购偏好。依产品类型分析，我们发现肾镜、碎石机及其配件之间有不同的趋势。诸如取石篮、扩张器器、导丝和导管导引线鞘套等配件属于高消耗品，对手术效率以及一次性使用与可重复使用的经济性有显着影响。对于碎石机平台而言，临床价值主要体现在碎石效率和维护模式上；而对于肾臟镜而言，可视化品质和人体工学设计则是关键的差异化因素。

手术类型细分显示，在临床上适当的情况下，微创手术正逐渐成为主流。微创和超微创手术优先考虑对实质组织的最小干扰，通常需要使用专用的低轮廓器械和精密的取石工具。对于结石负荷较大的患者，微创和标准手术仍然至关重要，需要强大的碎石能力和高效的排放途径。终端用户环境的差异正在影响其购买和使用行为。无论是独立运作的还是医院附属的门诊手术中心，通常更注重手术量、易于消毒以及耗材消耗的可预测性。

技术细分揭示了能量选择（雷射、气动或超音波）如何影响临床工作流程和资金配置。雷射平台通常需要辅助光纤组件和特定的维护方案；气动系统为某些类型的结石提供稳健且简便的解决方案；超音波设备则将碎石与抽吸功能相结合，可在特定临床情况下加速结石清除。肾结石和鹿角状结石在应用上的差异导致了不同的手术方案和设备组合，鹿角状结石病例通常需要多通道策略和联合能量方法。

最后，成人和儿童患者群体之间的患者类型划分导致了独特的设备和手术要求：儿科实践强调小型化器械和手术全期通讯协定，以最大限度地减少对肾实质的影响和麻醉暴露，而成人实践则包括更广泛的手术范围和对合併症管理的考虑，这会影响器械的选择和辅助技术。

区域观点下的采用模式、监管差异、製造节点和临床实务差异，共同驱动全球医疗器材策略。

区域动态对经皮肾结石治疗技术的应用和商业化有显着影响。在美洲，强大的私人医疗机构网路和集中的门诊设施正在加速微创技术的应用。经皮，监管路径和报销模式持续影响医院和门诊中心之间的资本投资模式和手术流程。该地区的供应链节点和本地製造能力也会影响医疗设备和配件的补货前置作业时间。

由于监管要求和医疗体系资金筹措的差异，欧洲、中东和非洲的能源平台普及速度不一。西欧的医疗中心通常专注于临床证据、培训和长期服务关係，而该地区的新兴市场则更注重成本效益高的解决方案和可扩展的培训模式。中东为卓越中心提供了投资机会，而非洲部分地区则面临基础设施限制，儘管临床上有需求，但这些限制阻碍了先进能源平台的普及应用。

在亚太地区，人口结构变化和部分市场手术量激增，推动了对高通量平台和高性价比耗材的需求。该地区的製造群和供应商生态系统支援产品的快速迭代和具有竞争力的定价模式。同时，临床实践模式和医院基础设施的多样性迫使供应商调整其商业化策略，提供模组化系统配置和区域培训计划，以确保手术结果的一致性。

竞争与创新的动态变化揭示了现有供应商和新参与企业如何塑造产品开发、服务模式和临床伙伴关係。

经经皮肾结石治疗领域的竞争格局反映了现有设备供应商与灵活参与企业优先考虑模组化设计、服务模式和临床伙伴关係。主要企业专注于提供整合解决方案，将高性能能量平台与优化的器械人体工学设计以及旨在减少停机时间的全面服务协议相结合。新参与企业则倾向于在狭窄的创新方向上竞争，例如一次性设备设计、增强型光纤技术以及简化的维护要求，以减少门诊操作中的摩擦。

整个产业的策略重点包括：透过多机构研究建立可靠的临床证据；扩大培训计画以缩短学习曲线；以及创建能够协调医疗服务提供者和支付奖励的商业模式。服务收入和耗材更换率对长期盈利仍然至关重要，这激励着供应商设计兼顾耐用性和灭菌要求的仪器。製造商与临床网路之间的伙伴关係日益普遍，从而能够快速反馈，不断改进产品，并有助于展现真正的价值提案，从而促进产品的更广泛应用。

为医疗设备製造商、医疗服务提供者和支付者提供策略建议，以提高肾结石清除手术的普及率、保障净利率并改善临床疗效。

产业领导者应采取一系列切实可行、基于实证的行动，以增强自身竞争力，同时帮助改善患者预后。首先，应优先开发模组化产品系列，使医疗机构能够根据手术复杂程度灵活调整设备规模，从而实现与单一供应商建立合作关係，为门诊中心和三级医院提供支援。其次，应投资于临床证据的收集和实践培训伙伴关係，以降低实施风险，并缩短复杂手术（尤其是微型手术）的学习曲线。

第三，透过多元化的采购和区域製造策略优化供应链韧性，降低关税波动和物流中断带来的风险。第四，设计灵活的商业模式，使供应商的奖励与设施的吞吐量和品质目标保持一致，例如与结果挂钩的定价、配套服务协议以及基于订阅的耗材获取方式。第五，加速数位化赋能能力的发展，例如程序分析和远距离诊断，以提高利用率指标并支持基于价值的合约。例如，儿科泌尿系统中心可能会优先考虑低调的儿科专用器械，而三级医疗机构则可能会确保配备强大的碎片化和排放工具，以应对复杂的鹿角状尿道畸形病例。

采用严谨的混合方法研究框架，整合临床医师的见解、采购观点和检验的二手证据，以得出可操作的资讯。

调查方法采用定性和定量相结合的研究方法，以获得对临床实践和商业性动态的三角验证且可重复的视角。主要资料收集工作包括对泌尿系统内视镜专家、门诊手术中心和医院的采购负责人、生物医学工程负责人以及医疗器材公司的高级产品经理进行结构化访谈。访谈内容涵盖了器械效用、维护实际情况、首选能量模式以及手术流程等方面的考量。

二次研究利用同行评审的临床文献、监管文件、临床试验註册库、医院采购文件和公开的技术规范，检验了设备的功能并绘製了其临床适应症图谱。资料综合采用主题编码来识别临床和营运方面的优先事项，并包含一个交叉检验步骤，将二级资讯来源与访谈结果进行比较，以减少偏差。为确保可比较性，在产品类型、手术类型、最终用户、技术、应用和患者类型方面均采用了一致的细分逻辑。本研究的局限性包括区域实践模式的差异以及设备迭代的快速发展，这可能导致短期偏差。儘管如此，本调查方法强调可重复性、透明的资讯来源归属以及敏感性分析，以突出共识和争议领域。

结论是基于临床发展、商业性压力以及为确定肾结石治疗服务的未来发展方向而进行的合作努力。

经皮肾结石治疗处于临床创新、营运优化和政策环境变化的交汇点。器械小型化、能量输送和可视化技术的进步拓展了手术选择，使临床医生能够针对成人和儿童患者制定个性化的治疗方案，同时应对包括肾结石和复杂鹿角状结石在内的各种临床应用。同时，医疗机构对门诊治疗的偏好以及支付方对医疗价值的重视，正在改变手术的进行地点和方式。

关税驱动的成本压力、区域製造业调整以及不断变化的采购惯例的综合影响，凸显了製定适应性强的商业策略和以循证医学为基础的产品设计的必要性。医疗服务主导和製造商若能积极合作，共同开展培训、服务模式和灵活的采购安排，将更有利于在控製成本的同时，维持高品质的医疗服务。展望未来，临床领导者、供应链相关人员和技术开发人员之间的持续合作，对于将创新成果转化为不同医疗体系中一致且易于获取的诊疗路径至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 门诊中心越来越多地采用小型化经皮肾镜取石系统
  • 整合先进的影像技术以提高经皮肾镜取石术的准确性
  • 更重视单步体外碎石术，以缩短手术时间和减少併发症
  • 在经皮肾镜取石术（PCNL）中，更多地使用超音波引导而非透视引导，以最大限度地减少辐射暴露。
  • 开发机器人经皮经皮肾镜取石平台以改善手术效果
  • 成本控制措施促使经皮经皮肾结石治疗服务扩大。
  • 为因应感染控制和消毒挑战，对一次性经皮肾镜取石术（PCNL）配件的需求不断增长。
  • 扩增实境可视化技术的进步有助于肾切开取石术中精准的肾臟穿刺

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章经皮皮肾结石切除术市场（依产品类型划分）

  • 配件
    • 篮子
    • 扩张器
    • 导管导引线
    • 鞘套
  • 体外碎石机
  • 肾镜

第九章经皮皮肾结石切除术市场（依手术类型划分）

  • 微
  • 小型的
  • 标准
  • 超迷你

第十章经皮皮肾结石切除术市场（依最终用户划分）

  • 门诊手术中心
    • 独立中心
    • 医院附设中心
  • 医院
    • 私立医院
    • 公立医院

第十一章经皮皮肾结石切除术市场：依技术分类

  • 雷射
  • 气动
  • 超音波

第十二章经皮皮肾结石清除术市场：依应用领域划分

  • 肾结石
  • 鹿角石

第十三章 依病患类型经皮的经皮肾结石切除市场

  • 成人版
  • 孩子们

第十四章经皮皮肾结石切除术市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 经经皮肾结石市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国经经皮肾结石市场分析

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Boston Scientific Corporation
    • KARL STORZ SE & Co. KG
    • Olympus Corporation
    • Richard Wolf GmbH
    • Stryker Corporation
    • Cook Medical LLC
    • Teleflex Incorporated
    • CONMED Corporation
    • Dornier MedTech GmbH
    • Lumenis Ltd.
Product Code: MRR-C002B1C99560

The Percutaneous Nephrolithotomy Market is projected to grow by USD 37.07 billion at a CAGR of 8.24% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 19.66 billion
Estimated Year [2025] USD 21.27 billion
Forecast Year [2032] USD 37.07 billion
CAGR (%) 8.24%

An authoritative overview of percutaneous nephrolithotomy that explains contemporary clinical practice, device ecosystems, and procedural variants shaping care delivery

Percutaneous nephrolithotomy is a cornerstone procedure in contemporary urologic practice for the management of complex and sizable renal calculi. Over recent years the procedure has evolved from an exclusively hospital-based intervention into a spectrum of access options characterized by variable instrument footprints, energy modalities, and perioperative pathways. These developments have been driven by parallel advances in device engineering, optics, and energy delivery systems as well as by changing expectations from patients and payers that prioritize shorter stays, faster recovery, and demonstrable safety outcomes.

In this context, clinical teams routinely consider an integrated set of products and procedural choices. Device categories central to the procedure include nephroscopes, lithotripters, and a broad suite of accessories such as baskets, dilators, guidewires, and sheaths. Procedure variants span micro, mini, standard, and ultra-mini approaches, each tailored to stone burden, renal anatomy, and patient comorbidity. End users range from ambulatory surgical centers, both freestanding and hospital affiliated, to private and public hospitals, with technology choices including laser, pneumatic, and ultrasonic modalities. Applications typically distinguish renal calculi from more extensive staghorn presentations, while patient populations differ between adult and pediatric cohorts. Taken together, these elements frame the contemporary clinical pathway and the commercial ecosystem that supports it.

How technological miniaturization, energy diversification, and site-of-care evolution are reshaping clinical routines and commercial strategies in nephrolithotomy

The landscape for percutaneous nephrolithotomy is undergoing several transformative shifts driven by technological, operational, and patient-centered forces. Technological miniaturization and enhancements in endoscopic optics have facilitated less invasive variants of the procedure, prompting clinicians to reconsider traditional size thresholds and perioperative requirements. Concurrently, energy platforms have diversified; laser systems have matured with improved fiber design and energy modulation, pneumatic and ultrasonic options remain important for specific stone compositions, and hybrid approaches have emerged to optimize fragmentation and evacuation.

Operationally, there is a clear movement toward ambulatory and accelerated recovery models. As clinicians and administrators adopt protocols that reduce length of stay without compromising safety, procedure selection and instrument portfolios are re-evaluated. Supply chain resilience and cost-efficiency have also assumed greater importance, encouraging hospitals and ambulatory centers to negotiate service agreements, consider single-use versus reusable trade-offs, and explore strategic sourcing alternatives. Finally, regulatory scrutiny and payer focus on outcomes and value are incentivizing manufacturers to provide robust clinical evidence and to support training programs that accelerate safe adoption of newer techniques and devices.

Assessing the operational and procurement repercussions of US tariff policy changes on device sourcing, manufacturing strategy, and provider purchasing behavior in 2025

Policy decisions influencing tariffs and trade in 2025 have produced material implications across the percutaneous nephrolithotomy supply chain. Manufacturers that rely on cross-border component sourcing have experienced higher landed costs, prompting procurement teams to revisit total cost of ownership calculations for capital equipment, disposables, and accessory portfolios. In response, some suppliers have accelerated regional manufacturing investments and adjusted distribution models to mitigate exposure to fluctuating duties and freight disruptions.

For providers, the cumulative effect has been a recalibration of purchasing cadence and inventory management. Hospitals and ambulatory centers have engaged in more rigorous vendor negotiations and have evaluated bundled service arrangements that shift inventory risk while preserving access to advanced lithotripsy and endoscopic platforms. Clinicians have observed impacts on device selection, as cost pressures can influence the choice between high-end reusable systems and competitively priced single-use alternatives, while research and development prioritization has leaned toward cost-efficient designs that retain clinical performance. In parallel, capital budgeting cycles have been adjusted to account for longer lead times and potential variability in consumable pricing, thereby reinforcing the importance of lifecycle service agreements and clinical evidence that justify higher initial investment.

Practical segmentation insights that link product classes, procedural variants, end user needs, energy modalities, clinical applications, and patient cohorts to purchasing and clinical preferences

Insights derived from product-level segmentation clarify how different device classes interact with clinical decisions and procurement preferences. The analysis of product type indicates distinct dynamics among nephroscopes, lithotripters, and accessories. Accessories such as baskets, dilators, guidewires, and sheaths function as high-volume consumables with important implications for procedure efficiency and single-use versus reusable economics. Lithotripter platforms concentrate clinical value in fragmentation efficiency and maintenance models, while nephroscopes implicate visualization quality and ergonomics as primary differentiators.

Procedure type segmentation highlights a progressive shift toward less invasive methods where clinically appropriate. Micro and ultra-mini approaches prioritize minimal parenchymal disruption and often require specialized, lower-profile instruments and refined stone extraction tools. Mini and standard procedures remain essential for larger stone burdens, demanding robust fragmentation capability and efficient evacuation pathways. Differences in end user environment shape purchasing and utilization behaviors. Ambulatory surgical centers, whether freestanding or hospital based, tend to emphasize throughput, ease of sterilization, and predictable consumable consumption, whereas private and public hospitals manage broader case complexity and typically maintain more diverse capital inventories.

Technology segmentation underscores how energy modality selection-laser, pneumatic, or ultrasonic-affects clinical workflows and capital allocation. Laser platforms often require ancillary fiber sets and specific maintenance frameworks, pneumatic systems offer rugged simplicity for certain stone types, and ultrasonic devices combine fragmentation with suction capabilities that can accelerate clearance for specific clinical scenarios. Application-based distinctions between renal calculi and staghorn calculi translate into different procedural planning and device combinations, with staghorn cases necessitating multi-tract strategies and often composite energy approaches.

Finally, patient type segmentation between adult and pediatric cohorts drives unique device and procedural requirements. Pediatric practice emphasizes miniaturized instruments and tailored perioperative protocols to minimize renal parenchymal impact and anesthesia exposure, whereas adult care encompasses a broader procedural repertoire and comorbidity management considerations that influence device selection and adjunctive technologies.

A region-by-region perspective on adoption patterns, regulatory variability, manufacturing nodes, and clinical practice differences driving device strategies globally

Regional dynamics exert a pronounced influence on how percutaneous nephrolithotomy technologies are adopted and commercialized. In the Americas, robust private-provider networks and a high concentration of ambulatory facilities have accelerated uptake of minimally invasive techniques, while regulatory pathways and reimbursement models continue to shape capital investment patterns and procedure routing between hospitals and outpatient centers. Supply chain nodes and local manufacturing capabilities in the region also influence lead times for capital equipment and accessory replenishment.

Across Europe, the Middle East, and Africa, heterogeneity in regulatory requirements and health system financing produces a patchwork of adoption speeds. Western European centers often emphasize clinical evidence, training, and long-term service relationships, whereas emerging markets within the broader region prioritize cost-effective solutions and scalable training models. The Middle East presents opportunities for centers of excellence investment, and parts of Africa contend with infrastructure limitations that constrain the adoption of advanced energy platforms despite clinical need.

In the Asia-Pacific region, demographic trends and high procedure volumes in select markets drive demand for both high-throughput platforms and cost-efficient consumables. Regional manufacturing clusters and supplier ecosystems support rapid product iteration and competitive pricing models. At the same time, variations in clinical practice patterns and hospital infrastructure require suppliers to adapt their commercialization strategies, offering modular system configurations and localized training initiatives to ensure consistent procedural outcomes.

Competitive and innovation dynamics revealing how established suppliers and nimble entrants are shaping product development, service models, and clinical partnerships

Competitive dynamics in the percutaneous nephrolithotomy space reflect a balance between established device providers and agile entrants that prioritize modularity, service models, and clinical partnerships. Leading companies focus on integrated solution sets that combine high-performance energy platforms with optimized instrument ergonomics and comprehensive service agreements designed to reduce downtime. Newer entrants often compete on narrow innovation vectors such as single-use instrument design, enhanced fiber technology, or simplified maintenance requirements that lower the operational friction for ambulatory settings.

Across the industry, strategic priorities include building robust clinical evidence through multicenter collaborations, expanding training programs that shorten the learning curve, and structuring commercial models that align incentives across providers and payers. Service revenue streams and consumable replacement rates remain important to long-term profitability, encouraging suppliers to design instruments that balance durability with sterilization demands. Partnerships between manufacturers and clinical networks are increasingly prevalent, enabling rapid feedback loops for iterative product improvements and helping to demonstrate real-world value propositions that support broader adoption.

Actionable strategic recommendations for device manufacturers, providers, and payers to accelerate adoption, protect margins, and improve clinical outcomes in nephrolithotomy

Industry leaders should pursue a set of pragmatic, evidence-driven actions to strengthen competitive positioning while supporting improved patient outcomes. First, prioritize development of modular product families that allow providers to scale instrument footprints to procedural complexity, enabling a single vendor relationship to support both ambulatory centers and tertiary hospitals. Second, invest in clinical evidence generation and hands-on training partnerships that reduce adoption risk and shorten the learning curve for advanced techniques, particularly for miniaturized procedures.

Third, optimize supply chain resilience through diversified sourcing and regional manufacturing strategies that reduce exposure to tariff volatility and logistic disruptions. Fourth, design flexible commercial models-such as outcome-linked pricing, bundled service agreements, and subscription-based access to consumables-that align vendor incentives with institutional goals for throughput and quality. Fifth, accelerate digital-enablement features, including procedure analytics and remote diagnostics for capital equipment, to improve utilization metrics and support value-based contracting. Finally, tailor product design for distinct patient cohorts and settings; for example, prioritize low-profile, pediatric-specific instruments for pediatric urology centers while ensuring robust fragmentation and evacuation tools for complex staghorn cases in tertiary facilities.

A rigorous, mixed-methods research framework that integrates clinician insights, procurement perspectives, and validated secondary evidence to produce actionable intelligence

The research approach combined qualitative and quantitative methods to ensure a triangulated, reproducible view of clinical practice and commercial dynamics. Primary data collection involved structured interviews with practicing endourologists, procurement leaders from ambulatory surgical centers and hospitals, biomedical engineering personnel, and senior product managers across device firms. These conversations explored device utility, maintenance realities, preferred energy modalities, and procedural workflow considerations.

Secondary research drew on peer-reviewed clinical literature, regulatory filings, clinical trial registries, hospital procurement documents, and publicly available technical specifications to validate device capabilities and to map clinical indications. Data synthesis employed thematic coding to identify recurring clinical and operational priorities, while cross-validation steps compared interview findings with secondary source signals to reduce bias. Segmentation logic was applied consistently across product type, procedure type, end user, technology, application, and patient type to ensure comparability. Limitations include variability in regional practice patterns and the rapid pace of device iteration that may introduce short-term divergence; nevertheless, the methodology emphasizes reproducibility, transparent source attribution, and sensitivity analyses to highlight areas of consensus and contention.

Concluding synthesis of clinical evolution, commercial pressures, and collaborative imperatives that will determine future trajectories for nephrolithotomy care delivery

Percutaneous nephrolithotomy stands at the intersection of clinical innovation, operational optimization, and shifting policy landscapes. Advances in device miniaturization, energy delivery, and visualization have expanded procedural options, enabling clinicians to tailor approaches across adult and pediatric populations while accommodating varied clinical applications such as renal calculi and complex staghorn disease. Simultaneously, provider preference for ambulatory pathways and payer emphasis on value are reshaping where and how procedures are performed.

The combined effects of tariff-driven cost pressures, regional manufacturing adjustments, and evolving procurement practices underscore the need for adaptable commercial strategies and evidence-backed product design. Providers and manufacturers that proactively align on training, service models, and flexible purchasing arrangements will be best positioned to sustain quality outcomes while managing cost imperatives. Looking forward, sustained collaboration between clinical leaders, supply chain stakeholders, and technology developers will be essential to translate innovation into consistent, accessible care pathways across diverse health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of miniaturized percutaneous nephrolithotomy systems in ambulatory centers
  • 5.2. Integration of advanced imaging technologies to enhance percutaneous nephrolithotomy precision
  • 5.3. Growing focus on single-step stone fragmentation devices to reduce procedure times and complications
  • 5.4. Increasing utilization of ultrasound guidance over fluoroscopy to minimize radiation exposure in PCNL
  • 5.5. Development of robotic-assisted percutaneous nephrolithotomy platforms for improved surgical outcomes
  • 5.6. Expansion of outpatient percutaneous nephrolithotomy services driven by cost containment initiatives
  • 5.7. Rising demand for disposable PCNL accessories to address infection control and sterilization challenges
  • 5.8. Advancements in augmented reality visualization aiding precise renal access during nephrolithotomy procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Nephrolithotomy Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Baskets
    • 8.1.2. Dilators
    • 8.1.3. Guidewires
    • 8.1.4. Sheaths
  • 8.2. Lithotripters
  • 8.3. Nephroscopes

9. Percutaneous Nephrolithotomy Market, by Procedure Type

  • 9.1. Micro
  • 9.2. Mini
  • 9.3. Standard
  • 9.4. Ultra Mini

10. Percutaneous Nephrolithotomy Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Freestanding Centers
    • 10.1.2. Hospital Based Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals

11. Percutaneous Nephrolithotomy Market, by Technology

  • 11.1. Laser
  • 11.2. Pneumatic
  • 11.3. Ultrasonic

12. Percutaneous Nephrolithotomy Market, by Application

  • 12.1. Renal Calculi
  • 12.2. Staghorn Calculi

13. Percutaneous Nephrolithotomy Market, by Patient Type

  • 13.1. Adult
  • 13.2. Pediatric

14. Percutaneous Nephrolithotomy Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Percutaneous Nephrolithotomy Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Percutaneous Nephrolithotomy Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Boston Scientific Corporation
    • 17.3.2. KARL STORZ SE & Co. KG
    • 17.3.3. Olympus Corporation
    • 17.3.4. Richard Wolf GmbH
    • 17.3.5. Stryker Corporation
    • 17.3.6. Cook Medical LLC
    • 17.3.7. Teleflex Incorporated
    • 17.3.8. CONMED Corporation
    • 17.3.9. Dornier MedTech GmbH
    • 17.3.10. Lumenis Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PERCUTANEOUS NEPHROLITHOTOMY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PERCUTANEOUS NEPHROLITHOTOMY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PERCUTANEOUS NEPHROLITHOTOMY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION